Abstract:Vaccines comprising innovative adjuvants are rapidly reaching advanced translational stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID-19 worldwide, offering new strategies to effectively combat diseases threatening human health. Adjuvants are vital ingredients in vaccines, which can augment the degree, extensiveness, and longevity of antigen specific immune response. The advances in the modulation of physicochemical properties of nanoplatforms elevate the capability of adjuvants in initiating the innate immune system and adaptive immunity, offering immense potential for developing vaccines against hard-to-target infectious diseases and cancer. In this review, we provide an essential introduction of the basic principles of prophylactic and therapeutic vaccination, key roles of adjuvants in augmenting and shaping immunity to achieve desired outcomes and effectiveness, and the physiochemical properties and action mechanisms of clinically approved adjuvants for humans. We particularly focus on the preclinical and clinical progress of highly immunogenic emerging nanotechnology adjuvants formulated in vaccines for cancer treatment or infectious disease prevention. We deliberate on how the immune system can sense and respond to the physicochemical cues ( e.g. , chirality, deformability, solubility, topology, and chemical structures) of nanotechnology adjuvants incorporated in the vaccines. Finally, we propose possible strategies to accelerate the clinical implementation of nanotechnology adjuvanted vaccines, such as in-depth elucidation of nano-immuno interactions, antigen identification and optimization by the deployment of high-dimensional multiomics analysis approaches, encouraging close collaborations among scientists from different scientific disciplines and aggressive exploration of novel nanotechnologies.

Guiding Principles in the Design of Molecular Bioconjugates for Vaccine Applications

Design of nanomaterial based systems for novel vaccine development

Biomaterials as vaccine adjuvants

Exploring structural engineering approach to formulate and characterize next-generation adjuvants

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action

Built-in adjuvants for use in vaccines

Adjuvant physiochemistry and advanced nanotechnology for vaccine development

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines

Design And Development Of Glycoconjugate Vaccines

Biological Nanoparticles in Vaccine Development

Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications

Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses

A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms

Modern Subunit Vaccines: Development, Components, and Research Opportunities

Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies

Advanced Subunit Vaccine Delivery Technologies:From Vaccine Cascade Obstacles to Design Strategies

Nanoparticles in Subunit Vaccines: Immunological Foundations, Categories, and Applications

Nanotechnology-Assisted Immunoengineering for Cancer Vaccines

Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines

Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines

Emerging Adjuvants For Cancer Immunotherapy